Rehan Ahmed, MD
Ophthalmology · Artificial Intelligence · Clinical Development

Rehan Ahmed, MD, MBA

Board-certified ophthalmologist and strategic advisor in drug & device development. I write, speak, and advise on what AI actually changes in eye care — in the clinic, in the data, and in the development pipeline.

Videos · Podcasts · Columns · Articles · A.I. in Eye Care ↗

Latest from the Media Archive

Browse the full archive →

About

I've spent my career at an unusual intersection — seeing patients as a practicing ophthalmologist while leading clinical development inside industry. I earned my MD at Vanderbilt, trained in ophthalmology at Baylor College of Medicine, and later added an MBA from MIT Sloan. As a strategist in Clinical Development working with multiple large pharmaceutical companies, I lived the other half of the equation: how a promising therapy actually navigates the development pathway. That vantage point shapes everything I write about AI — the algorithm is only half the product. The other half is the clinic it has to live in and the pipeline it has to survive.

Today I co-edit the A.I. in Eye Care eJournal (Jobson/WebMD) alongside Dr. Scot Morris and host the AI in Eye Care podcast — tracking oculomics, autonomous screening, smart glasses, and the business of bringing intelligent tools into eye care. I also co-founded Eyelomics and Muse AI, advise med-tech startups including Blink by Globe Biomedical, teach as Adjunct Assistant Professor at UT Southwestern, and serve as AI consultant to the Texas Medical Association's Health Information Technology Committee.

OculomicsAutonomous DR screeningAI & clinical developmentSmart glassesPractice workflow & reimbursement

The A.I. in Eye Care Platform

eJournal · Jobson/WebMD

A.I. in Eye Care eJournal

Co-Editor of the weekly publication keeping ophthalmologists and optometrists current on AI — original columns, news analysis, tools, and education.

Podcast

AI in Eye Care Podcast

Conversations with the clinicians, founders, and researchers building AI's future in eye care.

Advisory

Industry & Clinical Development

Advising med-tech startups and industry on bridging the gap between promising algorithms and products that succeed in real clinics and real regulatory pathways.

Leadership & Affiliations

Practice

President, Private Practice Ophthalmology

Practicing ophthalmologist — cataract and refractive surgery, MIGS, and medical retina.

Practice

Texas Eye and Vision Associates

An independent medical practice with multiple offices located throughout the state of Texas.

Co-Founder

Eyelomics

The retina as a window on systemic health — where oculomics meets clinical practice. Developed the AI Severity Index for visual field staging with Carrot (AAO 2026 poster).

Co-Founder

Muse AI

Re-imagining how people discover eyewear.

Advisory

Chief Medical Officer, Blink

Blink by Globe Biomedical — an AI-based ocular healthcare platform.

Academic

Adjunct Assistant Professor

University of Texas Southwestern Medical Center.

Policy

AI Consultant, Texas Medical Association

Expert consultant on augmented and artificial intelligence to the Committee on Health Information Technology.

Industry · Prior

Medical Director, Santen

Global Clinical Development and Operations, 2021–2023.

MD, Vanderbilt University School of Medicine · Ophthalmology residency, Baylor College of Medicine · MBA, MIT Sloan School of Management · BA in Philosophy, University of Illinois at Chicago. Recipient of the Barry M. Goldwater Scholarship and the Donald Gass Award in Ophthalmology; author of peer-reviewed publications including work on diabetic retinopathy screening.

Selected Writing

I write a monthly column on where AI actually meets the clinic — practical, skeptical, and grounded in real practice. The five most recent:

October 2026 · Column

Oculomics Has a Math Problem — and a Workflow Answer

Why a good oculomics algorithm still produces mostly false alarms, and the three changes to who gets tested that fix it.

September 2026 · Column

AI and the End of Humanity

Nobody outside the labs knows the real risk. What eye care should do with the question, and why AI needs independent oversight.

August 2026 · Column

The Friction Is the Curriculum: Raising Kids—and Physicians—in the AI Era

A question from my 7-year-old, an old encyclopedia, and what it means to train physicians when retrieval is solved.

July 2026 · Column

Cathedral Thinking: Notes from Venice and Milan

Why the most important work in AI and eye care is the kind you'll never see finished.

June 2026 · Column

The Unbundling of the Eye Exam

AI is splitting the exam into pieces. When the parts leave the room, who owns the patient?

Read all twenty-six columns — plus every podcast episode and video →

Research & Presentations

October 2026 · Scientific Poster PO431 · AAO 2026, New Orleans

AI-Derived Staging of VF Severity Using Large-Scale VR-Based Perimetry

Yousefi S, Ahmed R, Brown C, Barlow J, Block C. AI-Derived Staging of VF Severity Using Large-Scale VR-Based Perimetry. Scientific Poster PO431. American Academy of Ophthalmology 2026 Annual Meeting; October 2026; New Orleans, LA.

Unsupervised machine learning on 50,000 reliable 24-2 visual fields from VR perimetry found four data-driven severity stages (Normal, Mild, Moderate, Advanced) and the mean deviation thresholds that separate them, with no expert labels. Developed by Eyelomics with Carrot; the method now powers Carrot's AI Severity Index.

Publications

  1. Ahmed R, Whitestone N. Bridging the Data Divide in Eye Care. Orbis International (online). August 2023. Read
  2. Peterson J, Ahmed R, Foroozan R. Monocular Vision Loss. In: Ettinger AB, Weisbrot DM, eds. Neurologic Differential Diagnosis: A Case-Based Approach. Cambridge University Press. 2014:494-497.
  3. Ahmed R, Coats DK, Yen MT. Periosteal flap fixation of the globe for surgical treatment of severe restrictive strabismus: a report of eight cases with outcomes. Binocular Vision & Strabology Quarterly. 2011;26(4):230-5. PubMed
  4. Ahmed R, Foroozan R. Transient monocular visual loss. Neurologic Clinics. 2010;28(3):619-29. DOI · PubMed
  5. Ahmed R, Khetpal V, Merin LM, Chomsky AS. Retrospective review of incidental retinal emboli found on diabetic retinopathy screening: is there a benefit to referral for work-up and possible management? Clinical Diabetes. 2008;26(4):179-182. DOI · PubMed
  6. Patel SG, Ahmed R, Rosenbaum BP, Rodgers SM. Local career guidance programs on the web. Medical Teacher. 2007;29(4):412. DOI · PubMed
  7. Uz T, Ahmed R, Akhisaroglu M, Kurtuncu M, Imbesi M, Dirim Arslan A, Manev H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience. 2005;134(4):1309-16. PubMed
  8. Akhisaroglu M, Ahmed R, Kurtuncu M, Manev H, Uz T. Diurnal rhythms in cocaine sensitization and in Period1 levels are common across rodent species. Pharmacology Biochemistry and Behavior. 2004;79(1):37-42. DOI · PubMed
  9. Uz T, Akhisaroglu M, Ahmed R, Manev H. The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology. 2003;28(12):2117-23. DOI · PubMed

Earlier scientific posters

  1. Ahmed R, Coats DK, Yen MT. Periosteal flap fixation in severe strabismus. ARVO Annual Meeting, Fort Lauderdale, FL, May 2011.
  2. Ahmed R, Shah HR, Holz ER, Carvounis PE. A comparison of baseline lesion characteristics associated with long-term response to fewer than 3 intravitreal anti-VEGF injections. ARVO Annual Meeting, Fort Lauderdale, FL, May 2010.
  3. Lauten WB, Ahmed R, Merin LM, Wise K, Chomsky AS. Relationship between asymptomatic retinal arteriolar emboli and all-cause mortality in type II diabetic patients. ARVO Annual Meeting, Fort Lauderdale, FL, May 2009.
  4. Dieckhaus MJ, Welch J, Ahmed R, Wise K, Merin LM, Lauten WB, Chomsky AS. Natural course of asymptomatic retinal arteriolar emboli in type II diabetic patients. ARVO Annual Meeting, Fort Lauderdale, FL, May 2009.
  5. Ahmed R, Merin LM, Chomsky AS. Degree of diabetic retinopathy and internal carotid artery stenosis in the presence of retinal arteriolar emboli. ARVO Annual Meeting, Fort Lauderdale, FL, April 2008.
  6. Ahmed R, Khetpal V, Merin LM, Chomsky AS. Retrospective review of retinal arterial emboli found on diabetic retinopathy screening by digital photography. ARVO Annual Meeting, Fort Lauderdale, FL, May 2007.
  7. Ahmed R, Kekley PH, Recchia FM, Sternberg P Jr. Evaluation of adherence to clinical practice guidelines in the treatment of age-related macular degeneration. ARVO Annual Meeting, Fort Lauderdale, FL, May 2006. Featured in Retinal Physician, October 2006.
  8. Patel SG, Ahmed R, Rosenbaum BP, Nguyen AT, Rahman SF, Reynolds PQ, Rodgers SM. Career guidance and the web: bridging the gap between the AAMC Careers in Medicine website and local career advising programs. AAMC GSA/MAS/OSR Joint Spring Meeting, Philadelphia, PA, April 2006.
  9. Uz T, Akhisaroglu M, Ahmed R, Nikolic D, Pajkovic N, van Breemen RB, Manev H. Pineal melatonin regulates circadian cocaine sensitization and striatal expression of clock gene Period1. College on Problems of Drug Dependence, Bal Harbour, FL, June 2003.

Research honors: J. Donald M. Gass Award in Ophthalmology (2008); National Eye Institute grant (2008). Full list on ORCID.

Speaking & Media

I speak to clinical audiences, industry teams, and investor groups on AI in eye care — grounded in practice, not hype. Signature topics: oculomics and the retina as a window on systemic disease; the real economics of autonomous screening; and why the AI is only half the product.

"Dr. Ahmed has become a pioneer in artificial intelligence applications within eye care." — CataractCoach, Podcast #144 with Uday Devgan, MD (Dec 2025)
Rehan Ahmed presenting on stage at an AI in eye care session
Rehan Ahmed presenting to an audience at a CooperVision / National Vision workshop
Speaking

Texas Medical Association

Presented on augmented intelligence at TMA's Business of Medicine Conference (San Antonio); featured in Texas Medicine.

Speaking

Vision Expo West 2024

Faculty for "The Artificial Intelligence Revolution: Practical Applications in Eye Care Today" — presented on the augmentation of clinical care (Las Vegas).

Speaking

Vision Expo West 2025

Faculty for "The AI Revolution: Navigating the Future" — charting the next five years of AI in clinical eye care (Las Vegas).

Speaking

YoungMD Connect

Invited faculty for the virtual workshop "Finding Purpose & Navigating Challenges Beyond Ophthalmology," on career and mindset for early-career physicians (Jan 2024).

Press

2020mag

Coverage of the A.I. in Eye Care eJournal launch.

Podcast Guest

Spread Love in Organizations

"Genuine Curiosity" — with host Naji Gehchan, on curiosity-driven leadership across medicine and entrepreneurship.

Interview

Ophthalmology Innovation Source (OIS)

"Quick Takes From Ophthalmology Start-Ups" — on Blink by Globe Biomedical.

Podcast Guest

Ophthalmology Business Podcast #60

"Strategies for Building a Portfolio Career: Balancing Ophthalmology and Entrepreneurship."

Podcast Guest

CataractCoach #144

On AI in ophthalmology, with Uday Devgan, MD.

Press

Women In Optometry

Coverage of "The AI Revolution" at Vision Expo West, naming me on "The Augmentation of Clinical Care."

Trade Press

Vision Monday

A.I. in Eye Care analysis on multimodal AI and eyecare triage.